Skip to main content

Advertisement

Fig. 4 | Clinical Epigenetics

Fig. 4

From: Epigenetic silencing of MEIS2 in prostate cancer recurrence

Fig. 4

Prognostic potential of MEIS2 RNA expression in three RP cohorts. Dichotomization of patients into low and high MEIS2 RNA expression groups was based on ROC curves of BCR status at 36 months follow-up (not shown). Kaplan-Meier BCR-free survival estimate of low/high MEIS2 RNA expression in three RP cohorts: a Long et al. (RNAseq), b Taylor et al. (microarray), and c TCGA (RNAseq). p values were calculated using log-rank tests

Back to article page